165 related articles for article (PubMed ID: 7789372)
1. Acute myocardial infarction in the young--the role of smoking. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.
Barbash GI; White HD; Modan M; Diaz R; Hampton JR; Heikkila J; Kristinsson A; Moulopoulos S; Paolasso EA; Van der Werf T
Eur Heart J; 1995 Mar; 16(3):313-6. PubMed ID: 7789372
[TBL] [Abstract][Full Text] [Related]
2. Outcome of thrombolytic therapy in relation to hospital size and invasive cardiac services. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.
Barbash GI; White HD; Modan M; Diaz R; Hampton JR; Heikkila J; Kristinsson A; Moulopoulos S; Paolasso EA; Van der Werf T
Arch Intern Med; 1994 Oct; 154(19):2237-42. PubMed ID: 7944845
[TBL] [Abstract][Full Text] [Related]
3. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
[TBL] [Abstract][Full Text] [Related]
4. The risk of stroke in patients with acute myocardial infarction after thrombolytic and antithrombotic treatment. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico II (GISSI-2), and The International Study Group.
Maggioni AP; Franzosi MG; Santoro E; White H; Van de Werf F; Tognoni G
N Engl J Med; 1992 Jul; 327(1):1-6. PubMed ID: 1598096
[TBL] [Abstract][Full Text] [Related]
5. [Usefulness and safety of intravenous thrombolytic therapy for elderly patients with acute myocardial infarction: relationship with cardiac rupture].
Sakai M; Imai T; Kuboki K; Maeda S; Ueda S; Kuwajima I; Ohkawa S; Matsushita S
J Cardiol; 1999 Mar; 33(3):153-61. PubMed ID: 10225195
[TBL] [Abstract][Full Text] [Related]
6. Six-month survival in 20,891 patients with acute myocardial infarction randomized between alteplase and streptokinase with or without heparin. GISSI-2 and International Study Group. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto.
Eur Heart J; 1992 Dec; 13(12):1692-7. PubMed ID: 1289101
[TBL] [Abstract][Full Text] [Related]
7. [Thrombolytic therapy for acute myocardial infarction: circadian sensitivity].
Kharash LM; Goldkhammer EI
Ter Arkh; 1999; 71(12):13-7. PubMed ID: 10647192
[TBL] [Abstract][Full Text] [Related]
8. Accelerated infusion of streptokinase in acute myocardial infarction results in better TIMI flow grade in infarct-related artery.
Dwivedi SK; Saran RK; Narain VS; Bansal S; Gupta R; Puri VK
Indian Heart J; 2000; 52(1):40-4. PubMed ID: 10820932
[TBL] [Abstract][Full Text] [Related]
9. Thrombolytic therapy use for acute myocardial infarction and outcome in Qatar.
Hadi HA; Al Suwaidi J; Bener A; Khinji A; Al Binali HA
Int J Cardiol; 2005 Jul; 102(2):249-54. PubMed ID: 15982492
[TBL] [Abstract][Full Text] [Related]
10. [Risk factors as prognostic factors of hospital mortality in patients with acute myocardial infarction].
Ivanusa M; Milicić D; Bozikov J; Ivanusa Z
Acta Med Croatica; 2007 Jun; 61(3):307-13. PubMed ID: 17629107
[TBL] [Abstract][Full Text] [Related]
11. [The safety and efficacy of systemic salvage thrombolysis in acute myocardial infarct].
Sarullo FM; Schicchi R; Schirò M; Americo L; Bonnì G; Faraone N; Di Pasquale P; Castello A; Mauri F
Ital Heart J Suppl; 2000 Jan; 1(1):81-7. PubMed ID: 10832123
[TBL] [Abstract][Full Text] [Related]
12. [Risk factors and physical activity levels at the onset of acute myocardial infarction in young men].
Miyamoto S; Goto Y; Sumida H; Yasuda S; Matsumoto T; Morii I; Daikoku S; Itoh A; Miyazaki S; Nonogi H
J Cardiol; 2000 Aug; 36(2):75-83. PubMed ID: 10955251
[TBL] [Abstract][Full Text] [Related]
13. [Clinical characteristics and hospital mortality of acute myocardial infarction in elderly patients treated with thrombolytic agents].
Pabón Osuna P; Bermeio García J; Arribas Jiménez A; Nieto Ballesteros F; Sáez Jiménez A; Martin Luengo C; Fernández Avilés F; de la Torre Carpete M; Garcimartín Cerrón I
Rev Esp Cardiol; 1996 Jul; 49(7):501-8. PubMed ID: 8754444
[TBL] [Abstract][Full Text] [Related]
14. [t-PA in thrombolytic therapy of acute myocardial infarct].
Rutsch W; Schmutzler H
Herz; 1994 Dec; 19(6):336-52. PubMed ID: 7843690
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of late potentials after myocardial infarction treated with systemic thrombolysis or primary percutaneous transluminal coronary angioplasty.
Bruna C; Rossetti G; Vado A; Racca E; Steffenino G; Dellavalle A; Ribichini F; Ferrero V; Menardi E; Uslenghi E
G Ital Cardiol; 1998 Jan; 28(1):3-11. PubMed ID: 9493040
[TBL] [Abstract][Full Text] [Related]
16. Time to treatment with thrombolytic therapy: determinants and effect on short-term nonfatal outcomes of acute myocardial infarction. Canadian GUSTO Investigators. Global Utilization of Streptokinase and + PA for Occluded Coronary Arteries.
Cox JL; Lee E; Langer A; Armstrong PW; Naylor CD
CMAJ; 1997 Feb; 156(4):497-505. PubMed ID: 9054819
[TBL] [Abstract][Full Text] [Related]
17. Age-related increase in mortality among patients with first myocardial infarctions treated with thrombolysis. The Investigators of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2).
Maggioni AP; Maseri A; Fresco C; Franzosi MG; Mauri F; Santoro E; Tognoni G
N Engl J Med; 1993 Nov; 329(20):1442-8. PubMed ID: 8413454
[TBL] [Abstract][Full Text] [Related]
18. Long-term mortality of patients with acute myocardial infarction in the United States and Canada: comparison of patients enrolled in Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I.
Kaul P; Armstrong PW; Chang WC; Naylor CD; Granger CB; Lee KL; Peterson ED; Califf RM; Topol EJ; Mark DB
Circulation; 2004 Sep; 110(13):1754-60. PubMed ID: 15381645
[TBL] [Abstract][Full Text] [Related]
19. [Acute myocardial infarction in young Japanese women].
Toyofuku M; Goto Y; Matsumoto T; Miyao Y; Morii I; Daikoku S; Itoh A; Miyazaki S; Nonogi H
J Cardiol; 1996 Dec; 28(6):313-9. PubMed ID: 8986854
[TBL] [Abstract][Full Text] [Related]
20. Outcome of different reperfusion strategies in patients with former contraindications to thrombolytic therapy: a comparison of primary angioplasty and tissue plasminogen activator. Primary Angioplasty in Myocardial Infarction (PAMI) Investigators.
Stone GW; Grines CL; Browne KF; Marco J; Rothbaum D; O'Keefe JH; Hartzler GO; Overlie P; Donohue B; Chelliah N; Vlietstra R; Puchrowicz-Ochocki S; O'Neill WW
Cathet Cardiovasc Diagn; 1996 Dec; 39(4):333-9. PubMed ID: 8958418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
